Skip to main content
Clinical Trials/ISRCTN54741248
ISRCTN54741248CompletedNot Applicable

The effect of continuation of anti-platelet agents on bleeding complications after dento-alveolar surgical procedures

Academic Medical Centre (AMC) (Netherlands)0 sites145 target enrollmentStarted: March 8, 2006Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
145

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Patient on antiplatelet therapy who has to be treated in the AMC at the Department of Oral and Maxillofacial surgery
  • 2. Approval of the prescribing physician
  • 3. At least 18 years old

Exclusion Criteria

  • 1. Known coagulation defect
  • 2. Use of oral anticoagulant treatment (vitamin K antagonists) or therapeutic heparin
  • 3. Severe kidney dysfunction (creatinine clearance <20 ml/min) or hepatic dysfunction
  • 4. Unstable coronary artery disease
  • 5. Patients younger than 18 years of age
  • 6. Refusal to provide informed consent
  • 7. Recent placement of a coronary stent (during the last 6 months)

Investigators

Sponsor
Academic Medical Centre (AMC) (Netherlands)

Similar Trials

The effect of continuation of... | Clinical Trial